National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

recombinant vaccinia-MUC-1 vaccine
A vaccine containing a recombinant vaccinia virus that encodes the gene for human mucin-1, a tumor-associated antigen. Upon administration, recombinant vaccinia-MUC-1 vaccine may elicit a MUC-1-specific cytotoxic T cell response against tumor cells bearing MUC-1. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:rV-MUC-1 vaccine
vaccinia-MUC-1 vaccine
Abbreviation:rV-MUC-1

Previous:recombinant tumor necrosis factor family protein, recombinant tyrosinase-related protein-2, recombinant vaccinia prostate-specific antigen vaccine, recombinant vaccinia-B7.1 vaccine, recombinant vaccinia-CEA(6D)-TRICOM vaccine
Next:recombinant vaccinia-multiepitope melanoma peptides-B7.1-B7.2 vaccine, recombinant vaccinia-NY-ESO-1 vaccine, recombinant vaccinia-TRICOM vaccine, Rectoid, reduced glutathione-L-cysteine-anthocyanins gel